Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ)
CNY 26.16
(3.28%)
CNY 26.16
(3.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 63.32 Million | 67.22 Million | 59.01 Million | 64.54 Million | 65.93 Million | 66.08 Million |
| Net Income | 50.5 Million | 40.72 Million | 52.01 Million | 49.74 Million | 54.61 Million | 41.36 Million |
| Depreciation & Amortization | 18.59 Million | 18.48 Million | 18.71 Million | 20.45 Million | 20.67 Million | 17.93 Million |
| Deferred income taxes | 725.03 Thousand | 48.32 Thousand | 250.83 Thousand | 615.9 Thousand | 2.34 Million | -1.6 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.11 Million | 17.5 Million | -7.92 Million | -568.98 Thousand | -5.4 Million | 1.13 Million |
| Other non-cash items | 33.85 Million | -9.49 Million | -3.79 Million | -5.09 Million | -3.94 Million | 5.64 Million |
| Investing Cash Flow | 81.42 Million | -394.4 Million | -18.06 Million | -30.51 Million | -61.94 Million | -30.6 Million |
| Investments in PPE | -123.17 Million | -54.39 Million | -21.18 Million | -14.51 Million | -13.24 Million | -31.08 Million |
| Acquisitions | 2.6 Million | 0.53 | 0.40 | - | 13.25 Million | 31.08 Million |
| Investment purchases | -1.04 Billion | -1.35 Billion | -145 Million | -16 Million | -138 Million | -20 Million |
| Sales/Maturities of investments | 1.25 Billion | 1.01 Billion | 148.12 Million | - | 89.28 Million | 20.48 Million |
| Other Investing Activities | 213.54 Million | - | - | -14.51 Million | -13.24 Million | -31.08 Million |
| Financing Cash Flow | -13.16 Million | 381.32 Million | -59.61 Thousand | -28.24 Million | -18.48 Million | -12.95 Million |
| Debt repayment | -237.3 Thousand | - | - | - | - | - |
| Dividends payments | -12.92 Million | -10.5 Million | - | -24.24 Million | -18.18 Million | -12.12 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -237.31 Thousand | 391.83 Million | -59.61 Thousand | -4 Million | -300 Thousand | -830 Thousand |
| Accounts receivables | 11.77 Million | 2.03 Million | -1.01 Million | 537.5 Thousand | -8.06 Million | 4.9 Million |
| Accounts payables | -4.38 Million | -2.03 Million | 1.01 Million | -537.5 Thousand | 8.06 Million | - |
| Inventory | -7.43 Million | 5.61 Million | -6.47 Million | 1.46 Million | 3.52 Million | -6.52 Million |
| Other working capital | -3.08 Million | 11.89 Million | -1.44 Million | -2.03 Million | -8.92 Million | 7.65 Million |
| Cash at beginning of period | 202.77 Million | 148.07 Million | 107.18 Million | 101.39 Million | 115.88 Million | 93.35 Million |
| Cash at end of period | 334.37 Million | 202.22 Million | 148.07 Million | 107.18 Million | 101.39 Million | 115.88 Million |
| Capital Expenditure | -123.17 Million | -54.39 Million | -21.18 Million | -14.51 Million | -13.24 Million | -31.08 Million |
| Effect of forex changes on cash | - | - | -0.14 | - | - | - |
| Net cash flow / Change in cash | 131.59 Million | 54.14 Million | 40.89 Million | 5.78 Million | -14.49 Million | 22.53 Million |
| Free Cash Flow | -59.84 Million | 12.82 Million | 37.82 Million | 50.02 Million | 52.69 Million | 35 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.61 Million | 10.4 Million | 14.04 Million | 9.2 Million | 50.5 Million | 10.97 Million |
| Depreciation & Amortization | - | 6.18 Million | 6.18 Million | 4.68 Million | 18.59 Million | 4.68 Million |
| Deferred income taxes | - | - | - | - | 725.03 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 4.37 Million | - | 1.26 Million | -3.11 Million | -228.92 Thousand |
| Other non-cash items | 5.2 Million | 21.87 Million | -2.97 Million | 20.41 Million | 33.85 Million | 2.29 Million |
| Investing Cash Flow | -24.82 Million | -90.99 Million | 2.64 Million | 77.66 Million | 81.42 Million | -30.34 Million |
| Investments in PPE | -54.16 Million | -23.98 Million | -41.3 Million | -32.93 Million | -123.17 Million | -64.27 Million |
| Acquisitions | - | - | - | 2.6 Million | 2.6 Million | 0.92 |
| Investment purchases | -279 Million | -290.42 Million | -191.04 Million | -130 Million | -1.04 Billion | -228 Million |
| Sales/Maturities of investments | 308.33 Million | 223.41 Million | 235 Million | 238 Million | 1.25 Billion | 261.93 Million |
| Other Investing Activities | - | -66.03 Million | 47.57 Million | 112.28 Million | 213.54 Million | - |
| Financing Cash Flow | -5.05 Million | -52.25 Million | -61.36 Million | -237.31 Thousand | -13.16 Million | -118.65 Thousand |
| Debt repayment | - | - | - | - | -237.3 Thousand | - |
| Dividends payments | - | -20.01 Million | - | - | -12.92 Million | - |
| Common Stock Repurchased | 93.43 Million | -93.43 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.05 Million | 61.36 Million | -61.36 Million | -237.31 Thousand | -237.31 Thousand | -118.65 Thousand |
| Accounts receivables | - | 2.1 Million | - | 11.77 Million | 11.77 Million | 1.58 Million |
| Accounts payables | - | - | - | - | -4.38 Million | - |
| Inventory | - | 3.67 Million | - | -7.43 Million | -7.43 Million | 1.67 Million |
| Other working capital | - | -1.39 Million | - | -3.08 Million | -3.08 Million | -3.48 Million |
| Cash at beginning of period | 169.01 Million | 286.71 Million | 334.37 Million | 232 Million | 202.77 Million | 250.45 Million |
| Cash at end of period | 152.63 Million | 169.57 Million | 286.71 Million | 334.37 Million | 334.37 Million | 231.44 Million |
| Capital Expenditure | -54.16 Million | -23.98 Million | -41.3 Million | -32.93 Million | -123.17 Million | -64.27 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -16.37 Million | -117.14 Million | -47.65 Million | 102.36 Million | 131.59 Million | -19.01 Million |
| Free Cash Flow | -39.33 Million | 2.12 Million | -30.23 Million | -7.99 Million | -59.84 Million | -51.01 Million |
JSG
002320
MRE
LGCB
300568
AB